180 related articles for article (PubMed ID: 24268617)
1. Systemic corticosteroids in acute chest syndrome: friend or foe?
Ogunlesi F; Heeney MM; Koumbourlis AC
Paediatr Respir Rev; 2014 Mar; 15(1):24-7. PubMed ID: 24268617
[TBL] [Abstract][Full Text] [Related]
2. Acute chest syndrome: sickle cell disease.
Paul RN; Castro OL; Aggarwal A; Oneal PA
Eur J Haematol; 2011 Sep; 87(3):191-207. PubMed ID: 21615795
[TBL] [Abstract][Full Text] [Related]
3. A short course of prednisone in the management of acute chest syndrome of sickle cell disease.
Kumar R; Qureshi S; Mohanty P; Rao SP; Miller ST
J Pediatr Hematol Oncol; 2010 Apr; 32(3):e91-4. PubMed ID: 20216237
[TBL] [Abstract][Full Text] [Related]
4. Acute chest syndrome in sickle cell disease.
Farooq S; Abu Omar M; Salzman GA
Hosp Pract (1995); 2018 Aug; 46(3):144-151. PubMed ID: 29648482
[TBL] [Abstract][Full Text] [Related]
5. Early initiation of inhaled corticosteroids does not decrease acute chest syndrome morbidity in pediatric patients with sickle cell disease.
Leonard A; Godiwala N; Herrera N; McCarter R; Sharron M; Meier ER
Blood Cells Mol Dis; 2018 Jul; 71():55-62. PubMed ID: 29550053
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary complications of sickle cell disease.
Khoury RA; Musallam KM; Mroueh S; Abboud MR
Hemoglobin; 2011; 35(5-6):625-35. PubMed ID: 21973051
[TBL] [Abstract][Full Text] [Related]
7. Chest pain in sickle cell disease.
Tonino SH; Nur E; Otten HM; Wykrzykowska JJ; Hoekstra JB; Biemond BJ
Neth J Med; 2013 Jun; 71(5):265-9. PubMed ID: 23799317
[TBL] [Abstract][Full Text] [Related]
8. Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome.
Bundy DG; Richardson TE; Hall M; Raphael JL; Brousseau DC; Arnold SD; Kalpatthi RV; Ellison AM; Oyeku SO; Shah SS
JAMA Pediatr; 2017 Nov; 171(11):1090-1099. PubMed ID: 28892533
[TBL] [Abstract][Full Text] [Related]
9. Risk of vaso-occlusive episodes in patients with sickle cell disease exposed to systemic corticosteroids: a comprehensive review.
Ferreira de Matos C; Comont T; Castex MP; Lafaurie M; Walter O; Moulis G; Dion J; Cougoul P
Expert Rev Hematol; 2022 Dec; 15(12):1045-1054. PubMed ID: 36412212
[TBL] [Abstract][Full Text] [Related]
10. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
11. Original Research: Acute chest syndrome in sickle cell disease: Effect of genotype and asthma.
Pahl K; Mullen CA
Exp Biol Med (Maywood); 2016 Apr; 241(7):745-58. PubMed ID: 26936083
[TBL] [Abstract][Full Text] [Related]
12. [Acute chest syndrome of adults suffering from sickle cell disease].
Quéré G; Tempescul A; Couturaud F; Paleiron N; Leroyer C; De Saint-Martin L
Rev Pneumol Clin; 2011 Dec; 67(6):335-41. PubMed ID: 22137276
[TBL] [Abstract][Full Text] [Related]
13. [Respiratory complications of sickle cell anemia in children: the acute chest syndrome].
Bertholdt S; Lê PQ; Heijmans C; Huybrechts S; Dedeken L; Devalck C; Schifflers S; Ferster A
Rev Med Brux; 2012; 33(3):138-44. PubMed ID: 22891585
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission.
Sobota A; Graham DA; Heeney MM; Neufeld EJ
Am J Hematol; 2010 Jan; 85(1):24-8. PubMed ID: 19957348
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease.
Strouse JJ; Takemoto CM; Keefer JR; Kato GJ; Casella JF
Pediatr Blood Cancer; 2008 May; 50(5):1006-12. PubMed ID: 17849474
[TBL] [Abstract][Full Text] [Related]
16. Association of Antibiotic Choice With Hospital Length of Stay and Risk Factors for Readmission in Patients With Sickle Cell Disease and Acute Chest Syndrome: An Observational Cohort Study.
Badaki-Makun O; Casella JF; Tackett S; Tao X; Chamberlain JM
Ann Emerg Med; 2020 Sep; 76(3S):S37-S45. PubMed ID: 32928460
[TBL] [Abstract][Full Text] [Related]
17. Recurrence of acute chest syndrome post stopping Crizanlizumab, the dilemma of stopping vs continuation in patient with sickle cell disease: case report.
Afana MS; Abu-Tineh M; Alshurafa A; Yasin AK; Ahmed K; Abdulgayoom M; Yassin MA
Hematology; 2023 Dec; 28(1):2229115. PubMed ID: 37519115
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
[TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury in sickle patients with painful crisis or acute chest syndrome and its relation to pulmonary hypertension.
Audard V; Homs S; Habibi A; Galacteros F; Bartolucci P; Godeau B; Renaud B; Levy Y; Grimbert P; Lang P; Brun-Buisson C; Brochard L; Schortgen F; Maitre B; Mekontso Dessap A
Nephrol Dial Transplant; 2010 Aug; 25(8):2524-9. PubMed ID: 20179008
[TBL] [Abstract][Full Text] [Related]
20. Improving care for children with sickle cell disease/acute chest syndrome.
Crabtree EA; Mariscalco MM; Hesselgrave J; Iniguez SF; Hilliard TJ; Katkin JP; McCarthy K; Velasquez MP; Airewele G; Hockenberry MJ
Pediatrics; 2011 Feb; 127(2):e480-8. PubMed ID: 21242225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]